196 related articles for article (PubMed ID: 20017819)
1. Clinical pharmacology of methadone in dogs.
Ingvast-Larsson C; Holgersson A; Bondesson U; Lagerstedt AS; Olsson K
Vet Anaesth Analg; 2010 Jan; 37(1):48-56. PubMed ID: 20017819
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentrations and behavioral, antinociceptive, and physiologic effects of methadone after intravenous and oral transmucosal administration in cats.
Ferreira TH; Rezende ML; Mama KR; Hudachek SF; Aguiar AJ
Am J Vet Res; 2011 Jun; 72(6):764-71. PubMed ID: 21627522
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of methadone hydrochloride after a single intramuscular administration in adult Japanese sika deer (Cervus nippon nippon).
Scala C; Marsot A; Limoges MJ; Locatelli Y; Simon N; Alvarez JC
Vet Anaesth Analg; 2015 Mar; 42(2):165-72. PubMed ID: 24962270
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability and pharmacokinetics of oral and injectable formulations of methadone after intravenous, oral, and intragastric administration in horses.
Linardi RL; Stokes AM; Keowen ML; Barker SA; Hosgood GL; Short CR
Am J Vet Res; 2012 Feb; 73(2):290-5. PubMed ID: 22280392
[TBL] [Abstract][Full Text] [Related]
5. The effect of fluconazole on oral methadone in dogs.
KuKanich B; KuKanich K; Rankin D; Locuson CW
Vet Anaesth Analg; 2019 Jul; 46(4):501-509. PubMed ID: 30982709
[TBL] [Abstract][Full Text] [Related]
6. The disposition and behavioral effects of methadone in Greyhounds.
KuKanich B; Borum SL
Vet Anaesth Analg; 2008 May; 35(3):242-8. PubMed ID: 18282261
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of a methadone constant rate infusion and their corresponding effects on thermal and mechanical nociceptive thresholds in dogs.
Amon T; Kästner SBR; Kietzmann M; Tünsmeyer J
BMC Vet Res; 2021 Jan; 17(1):35. PubMed ID: 33461553
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of a proprietary l-methadone/fenpipramide combination (Polamivet) alone and in addition to acepromazine in healthy Beagle dogs.
Tünsmeyer J; Vaske B; Bösing B; Kästner SB
Vet Anaesth Analg; 2012 Sep; 39(5):451-63. PubMed ID: 22788416
[TBL] [Abstract][Full Text] [Related]
9. Methadone in healthy goats - pharmacokinetics, behaviour and blood pressure.
Olsén L; Olsson K; Hydbring-Sandberg E; Bondesson U; Ingvast-Larsson C
Res Vet Sci; 2013 Aug; 95(1):231-7. PubMed ID: 23540608
[TBL] [Abstract][Full Text] [Related]
10. A comparison of extradural and intravenous methadone on intraoperative isoflurane and postoperative analgesia requirements in dogs.
Leibetseder EN; Mosing M; Jones RS
Vet Anaesth Analg; 2006 Mar; 33(2):128-36. PubMed ID: 16476003
[TBL] [Abstract][Full Text] [Related]
11. Effects of medetomidine, L-methadone, and their combination on arterial blood gases in dogs.
Raekallio MR; Räihä MP; Alanen MH; Sarén NM; Tuovio TA
Vet Anaesth Analg; 2009 Mar; 36(2):158-61. PubMed ID: 19239654
[TBL] [Abstract][Full Text] [Related]
12. The effects of concurrent administration of cytochrome P-450 inhibitors on the pharmacokinetics of oral methadone in healthy dogs.
Kukanich B; Kukanich KS; Rodriguez JR
Vet Anaesth Analg; 2011 May; 38(3):224-30. PubMed ID: 21492388
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of buprenorphine in healthy, lactating goats.
Ingvast-Larsson C; Svartberg K; Hydbring-Sandberg E; Bondesson U; Olsson K
J Vet Pharmacol Ther; 2007 Jun; 30(3):249-56. PubMed ID: 17472657
[TBL] [Abstract][Full Text] [Related]
14. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
[TBL] [Abstract][Full Text] [Related]
15. Use of a von Frey device for evaluation of pharmacokinetics and pharmacodynamics of morphine after intravenous administration as an infusion or multiple doses in dogs.
KuKanich B; Lascelles BD; Papich MG
Am J Vet Res; 2005 Nov; 66(11):1968-74. PubMed ID: 16334958
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats.
Doodnaught GM; Monteiro BP; Benito J; Edge D; Beaudry F; Pelligand L; Steagall P
PLoS One; 2017; 12(4):e0176443. PubMed ID: 28445495
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of butorphanol in llamas after intravenous and intramuscular administration.
Carroll GL; Boothe DM; Hartsfield SM; Martinez EA; Spann AC; Hernandez A
J Am Vet Med Assoc; 2001 Nov; 219(9):1263-7. PubMed ID: 11697372
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of hydromorphone hydrochloride in healthy dogs.
KuKanich B; Hogan BK; Krugner-Higby LA; Smith LJ
Vet Anaesth Analg; 2008 May; 35(3):256-64. PubMed ID: 18282253
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of hydrorphone hydrochloride after intravenous and subcutaneous administration in ferrets (Mustela putorius furo).
Hech B; Knych H; Desprez I; Weiner D; Ambros B
Vet Anaesth Analg; 2024; 51(2):152-159. PubMed ID: 38158281
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of methadone enantiomers in hospice patients with cancer pain.
Auret K; Roger Goucke C; Ilett KF; Page-Sharp M; Boyd F; Oh TE
Ther Drug Monit; 2006 Jun; 28(3):359-66. PubMed ID: 16778720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
